CD8A and type 1 diabetes mellitus: Islets of Langerhans, which normally express very low levels of HLA-I (1), hyperexpress these CD8+ T cell recognition platforms in patients with T1D (2–4), and abrogation of major histocompatibility complex (MHC) class I expression in NOD mice confers disease protection (5, 6).